Novel treatments for major depressive disorder (Q83755824)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19407718%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Novel treatments for major depressive disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19407718%20AND%20SRC:MED&resulttype=core&format=json

major depressive disorder

27 January 2020

main subject

1 reference

R B Lydiard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19407718%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

1 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19407718%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19407718%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19407718%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

3 Suppl 5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19407718%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

11-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19407718%20AND%20SRC:MED&resulttype=core&format=json

Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

Treatment resistant depression--advances in somatic therapies

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

Neurostimulation therapies in depression: a review of new modalities

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

Paroxetine/bupropion combination treatment for refractory depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900003588

7 January 2021

10.1017/S1092852900003588

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19407718%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference